Fourrier A - Search Results

1

Cryopreserved cGMP-compliant human pluripotent stem cell-derived hepatic progenitors rescue mice from acute liver failure through rapid paracrine effects on liver cells.

Gantier M, Rispal R, Fourrier A, Ménoret S, Delbos F, Anegon I, Nguyen TH. Gantier M, et al. Among authors: fourrier a. Stem Cell Res Ther. 2024 Mar 12;15(1):71. doi: 10.1186/s13287-024-03673-9. Stem Cell Res Ther. 2024. PMID: 38475825 Free PMC article.

2

Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.

Caron J, Pène V, Tolosa L, Villaret M, Luce E, Fourrier A, Heslan JM, Saheb S, Bruckert E, Gómez-Lechón MJ, Nguyen TH, Rosenberg AR, Weber A, Dubart-Kupperschmitt A. Caron J, et al. Among authors: fourrier a. Stem Cell Res Ther. 2019 Jul 29;10(1):221. doi: 10.1186/s13287-019-1342-6. Stem Cell Res Ther. 2019. PMID: 31358055 Free PMC article.

3

Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells.

Fourrier A, Delbos F, Menoret S, Collet C, Thi Thuy LT, Myara A, Petit F, Tolosa L, Laplanche S, Gómez-Lechón MJ, Labrune P, Anegon I, Vallier L, Garnier D, Nguyen TH. Fourrier A, et al. Xenotransplantation. 2020 Jan;27(1):e12544. doi: 10.1111/xen.12544. Epub 2019 Jul 25. Xenotransplantation. 2020. PMID: 31342573

4

Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system.

Garnier D, Li R, Delbos F, Fourrier A, Collet C, Guguen-Guillouzo C, Chesné C, Nguyen TH. Garnier D, et al. Among authors: fourrier a. Sci Rep. 2018 May 29;8(1):8222. doi: 10.1038/s41598-018-26584-1. Sci Rep. 2018. PMID: 29844473 Free PMC article.

5

[Pulmonary nocardiosis with cerebral abscesses mimicking metastatic lung cancer: Three cases and a review of literature].

Fourrier A, Kerjouan M, Piau C, Lentz PA, Ricordel C, Léna H, Corre R, Desrues B, Jouneau S. Fourrier A, et al. Rev Mal Respir. 2017 Nov;34(9):1016-1021. doi: 10.1016/j.rmr.2017.08.002. Epub 2017 Sep 15. Rev Mal Respir. 2017. PMID: 28918971 Review. French.

6

RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Klinck R, Fourrier A, Thibault P, Toutant J, Durand M, Lapointe E, Caillet-Boudin ML, Sergeant N, Gourdon G, Meola G, Furling D, Puymirat J, Chabot B. Klinck R, et al. Among authors: fourrier a. PLoS One. 2014 Sep 11;9(9):e107324. doi: 10.1371/journal.pone.0107324. eCollection 2014. PLoS One. 2014. PMID: 25211016 Free PMC article.

7

Prediction of hydration free energies for the SAMPL4 diverse set of compounds using molecular dynamics simulations with the OPLS-AA force field.

Beckstein O, Fourrier A, Iorga BI. Beckstein O, et al. Among authors: fourrier a. J Comput Aided Mol Des. 2014 Mar;28(3):265-76. doi: 10.1007/s10822-014-9727-1. Epub 2014 Feb 21. J Comput Aided Mol Des. 2014. PMID: 24557853

8

Risk factors for acute decompensation of chronic kidney disease in hospitalized patients in the nephrology department: a case-control study.

Mahmoud LB, Pariente A, Kammoun K, Hakim A, Ghozzi H, Sahnoun Z, Fourrier A, Hachicha J, Zeghal K. Mahmoud LB, et al. Among authors: fourrier a. Clin Nephrol. 2014 Feb;81(2):86-92. doi: 10.5414/CN107948. Clin Nephrol. 2014. PMID: 24219912

9

The public health benefit of medicines: how it has been assessed in France? The principles and results of five years' experience.

Maison P, Zanetti L, Solesse A, Bouvenot G, Massol J; ISPEP group of the French National Authority for Health. Maison P, et al. Health Policy. 2013 Oct;112(3):273-84. doi: 10.1016/j.healthpol.2013.04.007. Epub 2013 May 10. Health Policy. 2013. PMID: 23664299

10

Guide de la Haute autorité de santé (HAS) : les études post-inscription sur les technologies de santé (médicaments, dispositifs médicaux et actes) : principes et méthodes.

Stamenkovic S, Solesse A, Zanetti L, Zagury P, Vray M; Le groupe « Intérêt de santé publique et études post-inscription » (ISPEP). Stamenkovic S, et al. Therapie. 2012 Sep-Oct;67(5):409-21. doi: 10.2515/therapie/2012065. Therapie. 2012. PMID: 27393714 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters